Search - tctmd.com

Displaying 301 - 311 of 311

Sort: Relevancy | Date

Presentation

IV Thrombolysis and Endovascular Therapy for Acute Ischemic Stroke with ICA Occlusion

Presenter: M. Mokin

July 23, 2012

Presentation

Intra-arterial Bone Marrow Mononuclear Cells in Ischemic Stroke

Presenter: Francisco Moniche

July 06, 2012

Presentation

Ren-Pro-Trial: Ischemic Preconditioning to Prevent Contrast-Induced Nephropathy

Presenter: Fikret Er

June 29, 2012

Presentation Fellows 2012

Revascularization for Stable Ischemic Heart Disease: Guidelines and Clinical Studies

Presenter: Nirat Beohar

April 21, 2012

Presentation

Relationship Between CYP2C19 Polymorphisms and Ischemic and Bleeding Outcomes in Stable Outpatients

Presenter: Deepak L. Bhatt

April 09, 2012

Presentation ACC 2012

Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial

Presenter: Emerson C. Perin

March 25, 2012

Presentation

Off-Pump vs. On-Pump Coronary Artery Bypass Grafting for Ischemic Heart Disease

Presenter: Christian H. M?ller

March 21, 2012

Presentation

Reduced Immediate Ischemic Events with Cangrelor in PCI: Pooled Analysis of the CHAMPION Trials Using the Universal Definition of MI

Presenter: 35236|Harvey White

March 16, 2012

Presentation

Procedural Factors Associated with PCI-Related Ischemic Stroke

Presenter: S. Hoffman

February 29, 2012

Presentation TCT 2012

Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial

Presenter: Thomas J. Povsic, John P. Vavalle, Laura H. Aberle, Steven L. Zelenkofske, Roxana Mehran, Mauricio G. Cohen, Christopher E. Buller, Jan H. Cornel, Jaroslaw D. Kasprzak, Gilles Montalescot, Peter Fail, Ian J. Sarembock, John H. Alexander

January 03, 2012

Presentation TCT 2012

Impact of the Different Route of Cell Delivery in Chronic Ischemic Cardiomyopathy Ovine Model

Presenter: Yanping Cheng, Geng-Hua Yi, Armando Tellez, Greg L. Kaluza, Juan F. Granada

January 03, 2012

Advertisement

IV Thrombolysis and Endovascular Therapy for Acute Ischemic Stroke with ICA Occlusion

Intra-arterial Bone Marrow Mononuclear Cells in Ischemic Stroke

Ren-Pro-Trial: Ischemic Preconditioning to Prevent Contrast-Induced Nephropathy

Revascularization for Stable Ischemic Heart Disease: Guidelines and Clinical Studies

Relationship Between CYP2C19 Polymorphisms and Ischemic and Bleeding Outcomes in Stable Outpatients

Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial

Off-Pump vs. On-Pump Coronary Artery Bypass Grafting for Ischemic Heart Disease

Reduced Immediate Ischemic Events with Cangrelor in PCI: Pooled Analysis of the CHAMPION Trials Using the Universal Definition of MI

Procedural Factors Associated with PCI-Related Ischemic Stroke

Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial

Impact of the Different Route of Cell Delivery in Chronic Ischemic Cardiomyopathy Ovine Model

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content